Fil LTD Exact Sciences Corp Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Fil LTD holds 5,049 shares of EXAS stock, worth $250,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,049

Holding current value

$250,127

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $214,229 - $357,620	5,049 New	5,049 $343,000
Q3 2017 Nov 13, 2017	SELL	$37.05 - $47.12 $1.53 Million - $1.95 Million	-41,391 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	41,391	41,391 $1.46 Million

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$880 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$785 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$710 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$598 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$331 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.77B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account